The rising preference of patients for the home-based treatments to reduce the growing healthcare expenditure of hospitals and clinics for treatment of chronic diseases is one of the major reasons for the adoption of drug infusion system at the global scale and is extensively used in hospitals and home care settings. The system enables safe, accurate and precise drug delivery, along with providing various opportunities to change the treatment options with respect to the needs of the patient.

According to the BIS Healthcare report titled, ‘Global Drug Infusion Systems Market-Analysis and Forecast (2017-2025),’ the market is expected to reach a value of $14.72 billion by the end of 2025 from $8.10 billion in the year 2016. This significant growth is attributed to the rise of chronic diseases, geriatric population, and has further led to the high demand for better medicine and facilities. In the forthcoming period, the market is expected to grow owing to the technological advancements and higher demands in the developing nations and increased usage of therapeutic indication.

The drug infusion system market consists of various infusion system products such as pumps, accessories, and disposables. These products are used for the administration of fluids and medication for a number of diseases and therapeutic areas such as diabetes, nutrition, oncology, and pediatrics, among others. Moreover, the pumps dominate the drug infusion market as these include large volume pumps, syringe pumps, insulin pumps, and elastomeric pumps.  The rising awareness regarding the use of infusion pumps is the main factor for the increased demand for such systems in the home care settings.

Conventional infusion pumps are more prone to cause medication errors as they required manual settings. These infusion pumps are set up to have maximum flexibility, so they can be used anywhere. Next generation of infusion devices, referred to as smart pump is setting a new standard of safety for iv medication administration, with demonstrated abilities to avert such errors. This commercially available infusion system conducts a reasonable test to check that programming is within pre-established institutional limits before infusion can begin.

Owing to the rise of home and alternate site infusion services, resulting from continued recognition of the benefits of home infusion therapy, is one of the driving factors for infusion system industry in the developed countries such as the U.S., Japan, and European countries. Moreover, in the developing nations, the increase in the chronic diseases and increased patient access to healthcare would escalate the growth of drug infusion in the forthcoming period. Geographically, North America holds the largest share of 32.7% in the global market owing to the technological innovations, growing adoption of infusion devices in homecare.     

BIS Research has conducted an extensive research on the global drug infusion systems market and compiled the observation and insight in this report. The market intelligence report aims at providing an in-depth analysis of the key development strategies, marketing strategies and market trend dynamics which include drivers, restraints, and opportunities prevailing in the industry.

For further queries, please write to us at sales@bisresearch.com or call us at: +1 650 228 0182.